ReachMD
Be part of the knowledge.™Episodes 1-8 of 8
Understanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
CME/CE Live BroadcastUnderstanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
June 19, 2023
11:00 AM - 12:00 PM EDT
Understanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
CME/CE Live BroadcastUnderstanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
June 21, 2023
03:00 PM - 04:00 PM EDT
How Socioeconomic Disparities Affect Outcomes Among Burkitt Lymphoma Patients
ASH Action CenterHow Socioeconomic Disparities Affect Outcomes Among Burkitt Lymphoma Patients
Immune Thrombocytopenia: Key Clinical Data on Cognitive Impairment
ASH Action CenterImmune Thrombocytopenia: Key Clinical Data on Cognitive Impairment
Updates on Sickle Cell Disease From ASH: A Hematologist’s Perspective
ASH Action CenterUpdates on Sickle Cell Disease From ASH: A Hematologist’s Perspective
Updates in SCD: Posters from the 64th ASH Annual Meeting
ASH Action CenterUpdates in SCD: Posters from the 64th ASH Annual Meeting
Bridging the Gaps in Care: Key Posters from the 64th Annual ASH Meeting
ASH Action CenterBridging the Gaps in Care: Key Posters from the 64th Annual ASH Meeting
A Look at Representation in Hematologic Clinical Trials
ASH Action CenterA Look at Representation in Hematologic Clinical Trials
